• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Antimicrobial Resistance (AMR)
  • Policy, Organisation and…
  • Quality of Life

Capturing the Broader Value of Antibiotics

STEDI Roadmap
Read more
  • Health Technology Assessment…
  • Economics of Innovation
  • Innovation

Innovation for Health System Efficiency and Improvement

Report picture
Read more
  • Drug Development/R&D
  • Value, Affordability, and…
  • Value based pricing

Proposals for a Novel UK Antimicrobial Subscription Model: How Will Antibiotic Innovation be Scored?

6
Read more
  • Antimicrobial Resistance (AMR)
  • Value, Affordability, and…

Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective

Proposal for a Novel Antimicrobial  Subscription
Read more
  • Health Care Systems
  • Policy, Organisation and…
  • Economic Evaluation

Reimagining Prevention for a Healthier, More Prosperous Society

Prev web
Read more
  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 23rd June 2016

OHE at PROMs Conference Sheffield 2016: Presentations and Posters

The inaugural PROMs Conference was held in Sheffield on Thursday 9th June 2016. This post contains presentations and posters given by the OHE team. The inaugural PROMs Conference was held in Sheffield on Thursday 9th June 2016. The aim of this…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

The inaugural PROMs Conference was held in Sheffield on Thursday 9th June 2016. This post contains presentations and posters given by the OHE team.

The inaugural PROMs Conference was held in Sheffield on Thursday 9th June 2016. The aim of this conference was to bring together leading researchers to discuss cutting edge developments in patient reported outcome measures (PROMs) research.

Several members of the OHE team attended and contributed to the one day conference. This post contains presentations and posters given by the OHE team.

Presentation: A new method for valuing patient-reported outcomes: direct elicitation of personal utility functions

Koonal Shah outlined a new stated preference approach for directly eliciting personal utility functions. He explained the concept underpinning the new approach, and presented results from piloting work to test the feasibility and acceptability of the approach in valuing EQ-5D.

A new method for valuing quality of life: Direct elicitation of personal utility functions from Office of Health Economics

 

Poster: A comparison of three EQ-5D value sets: Implications for the analysis of routinely collected EQ-5D data

The following poster was presented by Koonal Shah. It compares three EQ-5D values sets: the UK EQ-5D-3L (MVH) value set; the EQ-5D-5L cross walk value set; and the new EQ-5D-5L value set for England.

A Comparison of Three EQ-5D Value sets from Office of Health Economics

 

Poster: Do you know what you are talking about? Differences in the TTO valuation of (currently) experienced and non-experienced health profiles

Patricia Cubi-Molla presented the following poster. It explores whether experiencing a certain health state affects the valuation of the health state.

OHE at PROMs Conference Sheffield 2016: Presentations and Posters from Office of Health Economics

 

Poster: The distribution of the EQ-5D-5L Index in patient populations

The distribution of the EQ-5D-3L index in patient populations often shows two distinct groups, arising both from the distribution of ill health and how the EQ-5D-3L index is constructed. This poster, presented by Yan Feng, describes a study which aims to explore (a) whether or not the EQ-5D-5L index distribution also demonstrates clustering; (b) the extent to which clustering of EQ-5D-5L profile data is a driver of any observed clustering of the EQ-5D-5L index; and the extent to which clusters are a product of the value sets used to estimate the EQ-5D-5L index; and (c) to highlight the implications of our results for statistical analysis of EQ-5D-5L index data.

The Distribution of the EQ-5D-5L Index in Patient Populations from Office of Health Economics

 

For further information on any of these presentations please contact the OHE authors via our Meet the Team webpage.

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Presentations

Related News

  • News
  • March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Read more
  • News
  • March 2020

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

Read more
  • News
  • January 2020

Funding Challenges in the Malaysian Health Care System

Read more
  • News
  • January 2020

OHE at HESG Winter 2020

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!